Mode
Text Size
Log in / Sign up
N/A N=10 Treatment

Time to Eat Study - Pilot

Overweight

Enrolled (actual)
10
Serious AEs
0.0%
Results posted
Dec 2024
Primary outcome: Primary: Number of Participants With Treatment-Emergent Adverse Events as a Measure of Safety and Tolerability — 3 Participants

Study Design & Population

Study type
Interventional
Phase
N/A
Interventions
Intermittent Fasting (Behavioral)
Age
Older Adult · 65+ yrs
Sex
All
Sponsor
University of Florida
Primary completion
Sep 2018

Outcome Measures

OutcomeResultp-value
PRIMARY
Number of Participants With Treatment-Emergent Adverse Events as a Measure of Safety and Tolerability
3
PRIMARY
Adherence
84
PRIMARY
Retention
1
PRIMARY
Recruitment Yields
65
SECONDARY
Body Weight
94.81
SECONDARY
Body Mass Index (BMI)
33.2
SECONDARY
Waist Circumference
109.23
SECONDARY
Blood Glucose
107.3
SECONDARY
Systolic Blood Pressure
148.22
SECONDARY
Diastolic Blood Pressure
78.89
SECONDARY
6 Minute Walk Test (Meters)
310.89
SECONDARY
6 Minute Walk Test (m/s)
0.92
SECONDARY
Grip Strength (Dominant Hand)
24.0
SECONDARY
12-Item Short Form Survey Physical Function (Summary Score)
14.9
SECONDARY
12-Item Short Form Survey Mental Function (Summary Score)
22.8
SECONDARY
12-Item Short Form Survey Total Score
37.7
SECONDARY
Fatigability Questionnaire (Mental Subscale)
14.7
SECONDARY
Fatigability Questionnaire (Physical Subscale)
24.9
SECONDARY
Montreal Cognitive Assessment
25.9
SECONDARY
Circulating (Plasma) microRNA
14; 8; 6

Summary

The goals of this pilot study is to evaluate the safety and feasibility of time restricted feeding in an older adult population.

Eligibility Criteria

Inclusion Criteria

  • Consent to participate in the study
  • Men and women ≥ 65 years old
  • Self-reported difficulty walking ¼ mile or climbing a flight of stairs
  • Self-reported sedentariness ( 12 hours per day
  • Actively trying to lose weight by participating in formal weight loss program or significantly restricting calorie intake
  • Weight loss > 5 lbs in the past month
  • Medical history or conditions
  • Resting heart rate of >120 beats per minute, systolic blood pressure > 180 mmHg or diastolic blood pressure of > 100 mmHg
  • Unstable angina, heart attack or stroke in the past 3 months
  • Continuous use of supplemental oxygen to manage a chronic pulmonary condition or heart failure
  • Rheumatoid arthritis, Parkinson's disease or currently on dialysis
  • Active treatment for cancer in the past year
  • Insulin dependent diabetes mellitus
  • Taking medications that preclude fasting for 16 hours (e.g. must be taken with food at least 12 hours apart)
  • Any condition that in the opinion of the investigator would impair ability to participate in the trial
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT03590847). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search